Class specific rheumatoid factors and antiphospholipid syndrome in systemic lupus erythematosus

Lupus

Volumn 9, Issue 1, 2000, Pages 56-60

  Spadaro, Antonio ^a   Riccieri, V ^a   Terracina, S ^a   Rinaldi, T ^a   Taccari, E ^a   Zoppini, A ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Anticardiolipin antibodies; Antiphospholipid syndrome; Rheumatoid factors

Indexed keywords

AUTOANTIBODY; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M ANTIBODY; PHOSPHOLIPID ANTIBODY; RHEUMATOID FACTOR;

ADOLESCENT; ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE MARKER; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0034066071     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/096120330000900110     Document Type: Article

References (32)

1. Feldman D, Feldman D, Ginzier E, Kaplan D. Rheumatoid factor in patients with systemic lupus erythematosus. J Rheumatol 1989; 16: 618-622.
2. Rossen RD, Reisberg MA, Sharp JT et al. Antiglobulins and glomerulonephritis. J Clin Invest 1975; 56: 427-437.
3. Rossen RD, Rickaway RH, Reisberg MA et al. Renal localization of antiglobulins in glomerulonephritis and after renal transplantation. Arthritis Rheum 1977; 29: 947-961.
4. Quismorio FP Jr, Sharma O, Koss M et al. Immunopathologic and clinical studies in pulmonary hypertension associated with systemic lupus erythematosus. Semin Arthritis Rheum 1984; 13: 349-359.
5. Kantor GL, Bickel YB, Barnett EV. Coexistence of systemic lupus erythematosus and rheumatoid arthritis. Report of a case and review of the literature, and clinical, pathologic and serologic observations. Am J Med 1969; 47: 433-444.
6. Baldwin DS, Lowenstein J, Rothfield NF et al. The clinical course of the proliferative and membranous forms of lupus nephritis. Ann Int Med 1970; 73: 929-942.
7. Pinillos RM, Solle JMN, Roura XJ et al. Rheumatoid factors in patients with systemic lupus erythematosus. Ann Rheum Dis 1987; 46: 877-878.
8. Stokes Turner L, Mones M, Addison I et al. Does rheumatoid factor protect lupus nephritis from the development of nephritis. Ann Rheum Dis 1989; 48: 14-16.
9. Tarkowski A, Westerburg G. Rheumatoid factor isotypes and renal disease in systemic lupus erythematosus. Scand J Rheumatol 1987; 16: 309-312.
10. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
11. Harris EN. Miscellaneous disorders. Antiphospholipid syndrome. In: Klippel JH, Dieppe PA (eds.) Rheumatology Mosby: London, 1998, section 7.35.1-6.
12. Alarcon-Segovia D, Pérez-Vazquez ME, Villa AR et al. Preliminary classification criteria for the antiphospholipid syndrome within systemic lupus erythematosus. Semin Arthritis Rheum 1992; 21: 275-286.
13. Vitali C, Bencivelli W, Isenberg DA et al. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. II. Identification of the variables indicative of disease activity and their use in the development of an activity score. Clin Exp Rheumatol 1992; 10: 541-547.
14. Bombardier C, Gladman DD, Urowitz MB et al and the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 1992; 35: 630-640.
15. Gladman D, Ginzler E, Goldsmith C et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index for systemic lupus erythematosus. Arthritis Rheum 1996; 39: 363-369.
16. Spadaro A, Riccieri V, Sili Scavelli A et al. One year treatment with low dose methotrexate in rheumatoid arthritis: effect on class specific rheumatoid factors. Clin Rheumatol 1993; 12: 357-360.
17. Gharavi AE, Harris EN, Asherson RA, Hughes JRV. Anticardiolipin antibodies: isotype distribution and phospholipid specificity. Ann Rheum Dis 1987; 46: 1-6.
18. Quisimorio FP. Other serologic abnormalities in systemic lupus erythematosus. In: Wallace DJ, Halm BH (ed.). Dubois' Lupus Erythematosus. Williams & Wilkins: Baltimore 1997. pp 523-543.
19. Howard TW, Iannini MJ, Burge JJ, Davis JS. Rheumatoid factor, cyroglobulinemia, anti-DNA and renal disease in patients with systemic lupus erythematosus. J Rheumutol 1991; 18: 826-830.
20. Hill GS, Hinglais N, Tron F, Bach JF. Systemic lupus erythematosus. Morphologic correlations with immunologic and clinical data at the time of biopsy. Am J Med 1978; 64: 61-79.
21. Helin H, Korpela M, Mustonen J, Pasernack A. Rheumatoid factors in rheumatoid arthritis associated renal disease in lupus nephritis. Ann Rheum Dis 1986; 45: 508-511.
22. Corke CE. Rheumatoid factor and renal disease in systemic lupus erythematosus. Rheumatol Rehab 1987; 17: 76-78.
23. Cervera R, Khamashta MA, Font J et al. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1000 patients. Medicine 1991; 72: 113-124.
24. Mustakallio KK, Lassus A, Putkonen T, Wager O. Cryoglobulins and rheumatoid factor in systemic lupus erythematosus. Acta Derm Venereol 1967; 47: 241-248.
25. Guerin J, Feighery C, Sim EB, Jackson J. Antibodies to beta2-glycoprotein I - a specific marker for the antophospholipid syndrome. Clin Exp Immunol 1997; 109: 304-309.
26. Merkel PA, Chang Y, Pierangeli SS et al. The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases. Am J Med 1996; 101: 576-583.
27. Piette JC. 1996 diagnostic and classification criteria for the antiphospholipid/cofactors syndrome: a mission impossible? Lupus 1996; 5: 354-363.
28. Levy RA. Clinical manifestation of the aPL syndrome. Lupus 1996; 5: 393-397.
29. Mannik M, Nardella FCR. IgG rheumatoid factors and self-association of these antibodies. Clin Rheum Dis 1985; 11: 551-572.
30. Petri M. Clinical and management aspects of the antiphospholipid syndrome. In: Wallace DJ, Hahn BH (ed.) Dubois' Lupus Erythematosus. Williams & Wilkins: Baltimore, 1997, pp 1067-1096.
31. Lie JT. Vasculopathy of the antiphospholipid syndromes revisited: thrombosis id the culprit and vasculitis the consort. Lupus 1996; 5: 368-371.
32. Lockshin MD. Pathogenesis of the antiphospholipid antibody syndrome. Lupus 1996; 5: 404-408.